FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Short Interest Update

Posted by Teresa Graham on Jun 30th, 2026

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT – Get Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totaling 9,169 shares, a decline of 52.0% from the May 31st total of 19,122 shares. Based on an average daily trading volume, of 5,705 shares, the short-interest ratio is currently 1.6 days. Approximately 0.1% of the company’s stock are sold short.

Hedge Funds Weigh In On FT Vest U.S. Equity Deep Buffer ETF – October

A hedge fund recently raised its stake in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC increased its position in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT – Free Report) by 4,725.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,993 shares of the company’s stock after purchasing an additional 119,465 shares during the period. FT Vest U.S. Equity Deep Buffer ETF – October makes up approximately 4.1% of Winnow Wealth LLC’s holdings, making the stock its 5th biggest position. Winnow Wealth LLC owned 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 at the end of the most recent reporting period.

FT Vest U.S. Equity Deep Buffer ETF – October Price Performance

Shares of FT Vest U.S. Equity Deep Buffer ETF – October stock opened at $46.52 on Tuesday. FT Vest U.S. Equity Deep Buffer ETF – October has a 1 year low of $40.87 and a 1 year high of $46.72. The firm has a market cap of $382.86 million, a price-to-earnings ratio of 24.90 and a beta of 0.37. The company has a 50-day moving average of $46.14 and a 200 day moving average of $44.93.

FT Vest U.S. Equity Deep Buffer ETF – October Company Profile

(Get Free Report)

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.